ESCALON MEDICAL CORP (ESMC)

Stammdaten

Escalon Medical Corp. develops, manufactures, markets, and distributes medical devices and pharmaceuticals in the area of ophthalmology in the United States and internationally. It offers A-Scan, which provides information about the internal structure of the eye; B-Scan, a diagnostic tool that supplies information to physicians where the media within the eye are cloudy or opaque; UBM, a high frequency/high resolution ultrasound device, which provides detailed information about the anterior segment of the eye; and Pachymeter that measures the thickness of cornea. The company also distributes intraocular gas products, such as C3F8 and SF6, which are used by vitreoretinal surgeons as a temporary tamponade in detached retina surgery; and manufactures and distributes a patented disposable universal gas kit that delivers the gas from the canister to the patient. In addition, it offers disposable surgical packs that are used in vitreoretinal surgery; and AXIS Image management system for managing images through the Web browser from various devices regardless of modality, manufacturer, or location. The company sells its products to medical institutions through independent sales representatives, a network of distributors, and internal sales employees. Escalon Medical Corp. was founded in 1987 and is headquartered in Wayne, Pennsylvania.

Unternehmen & Branche

NameESCALON MEDICAL CORP
TickerESMC
CIK0000862668
BoerseUS
SektorHealthcare
IndustrieMedical - Devices
SIC3845 · Electromedical & Electrotherapeutic Apparatus

Wertpapier & Kennzahlen

CUSIP
ISIN
TypCommon Stock

Externe Quellen: SEC EDGAR » · FMP-Profil » · Yahoo Finance »

Finanzkennzahlen (SEC XBRL)

PeriodeFilingUmsatzNettoergebnisEPSAktivaEigenkapital
2025-12-3110-Q97,6770.014,980,0011,772,932
2025-09-3010-Q-239,852-0.034,581,6391,675,255
2025-06-3010-K105,5250.004,993,0591,915,107
2025-03-3110-Q3,474,192271,4720.025,215,3662,294,858
2024-12-3110-Q3,220,556246,0210.024,486,5012,023,386
2024-09-3010-Q-32,217-0.014,719,1161,777,365
2024-06-3010-K-125,261-0.024,757,9251,809,582
2024-03-3110-Q2,695,501-162,149-0.024,599,0311,675,176
2023-12-3110-Q2,869,237-76,321-0.014,706,2631,837,325
2023-09-3010-Q2,945,000-21,1970.004,928,4341,913,646
2023-06-3010-K456,8260.035,307,9511,934,843
2023-03-3110-Q3,434,314585,2350.045,120,8221,736,485
2022-12-3110-Q3,005,489-6,0430.004,641,7351,151,250
2022-09-3010-Q2,604,816-320,724-0.054,926,9981,157,293
2022-06-3010-K18,0810.005,172,2371,478,017
2022-03-3110-Q2,416,127-320,724-0.045,014,7011,157,293
2021-12-3110-Q2,700,757-53,154-0.015,237,6371,724,002
2021-09-3010-Q2,675,069317,2200.025,461,4191,777,156
2021-06-3010-K-52,023-0.015,682,8661,459,936
2021-03-3110-Q2,324,907-137,465-0.025,576,7871,276,417

Fondsaktivität (Vorquartalsvergleich)

Keine Fondsdaten für dieses Unternehmen vorhanden.

Insider-Transaktionen (12 Monate)

Keine Insider-Käufe/Verkäufe in den letzten 12 Monaten.

Top-Fondshalter

Keine Fondsdaten zu dieser Aktie vorhanden.

Hinweis

Erweitert ×